SC-43

N/A

Report date: 2024/11/23 20:00:08
NME

Base Information

Drug NameSC-43
Drug Alias NameSC-43
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBiliary Tract Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSupremecure Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSupremecure Pharma IncRaND Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBiliary Tract Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A